Updated information and figures on obesity rates for the United States and worldwide was added.
Additional information on the Maudsley approach to treating anorexia nervosa has been included.
New information on genetic determinates of eating disorders was added.
Chapter 11: Sexual Disorders and Gender Dysphoria
A new feature box, Understanding Changes in DSM–5, describes considerations and changes in criteria related to sexual disorders and gender-related experiences.
A new LENS was added: Transgender: Bruce Jenner’s Journey to Caitlyn Jenner.
Updated research concerning nontraditional sexual practices has been included.
New brain imaging research with pedophiles has been incorporated.
Additional research concerning hormones during gestation and later sexual experiences was added.
Chapter 12: Substance-Related and Addictive Disorders
A new feature box, Understanding Changes in DSM–5, describes considerations and changes in criteria related to substance-related and addictive disorders.
An updated LENS on the Legalization of Marijuana is included.
A new LENS, Drug Use—Rehabilitation, Not Jail, describes local government programs that focus on rehabilitation rather than jail time.
Updated information and figures on use of illicit drugs in the United States and worldwide have been added.
Updated information on brain changes with drug use has been included.
Updated research on genetic associations with drug dependence has also been added.
Chapter 13: Schizophrenia
A new LENS has been included: Elyn Saks Describes Her Day-to-Day Experiences With Schizophrenia.
Another new LENS, Mental Health Networks of Those With Serious Mental Disorders, was also included.
A new feature box, Understanding Changes in DSM–5, describes considerations and changes in criteria related to schizophrenia.
A new feature box, Research Terms to Know, describes factor analysis.
Additional information on endophenotypes related to schizophrenia was added.
New genetic information concerning schizophrenia, including variations in the HMC locus component 4 (C4), has been incorporated.
Factor analysis research has been included describing cognitive factor deficits seen in schizophrenia.
Updated research concerning white matter and gray matter brain changes seen in schizophrenia was added.
Updated information on research seeking to predict who will develop schizophrenia has also been included.
New treatment approaches (e.g., NAVIGATE) are described that are designed for the treatment of first episode psychosis.
Updated information on the use of neuroleptic medication to treat schizophrenia was added.
Chapter 14: Personality Disorders
A new feature box, Understanding Changes in DSM–5, describes considerations and changes in criteria related to personality disorders.
A new Cultural LENS was added: Global Mental Health: Personality Disorders.
An update of the prevalence of personality disorders has been incorporated.
Additional information on the treatment of personality disorders other than borderline personality disorder is included.
Chapter 15: Neurocognitive Disorders
A new LENS was added: Dementia-Friendly Communities.
A new feature box, Understanding Changes in DSM–5, describes considerations and changes in criteria related to neurocognitive disorders.
Updated information and figures have been included related to the aging of the U.S. and worldwide populations versus the number of people under the age of 5.
New information has been added on brain changes in individuals with Alzheimer’s disease.
New research such as the ACTIVE study of 2,832 individuals on the ability to delay or prevent decline in cognitive abilities has been included.
New research has been added on individuals over 90 years of age in terms of the factors involved in successful aging.
New research has been incorporated showing that the prevalence of neurocognitive disorders has decreased in both the United States and the UK.
Chapter 16: The Law and Mental Health
A new LENS was added: The Implications of Solitary Confinement.
A new Cultural LENS was added: Global Mental Health: Prisoners and Mental Health.
A new feature box, Understanding Changes in DSM–5, describes considerations and changes related to legal issues.
An update has been added on legal issues of using psychotropic medications to restore competency.
Clarification of differences between duty to protect and duty to warn has been incorporated.
New legal considerations related to adolescents being treated legally as an adult and court decision related to life in prison for adolescents have been included.
Acknowledgments
I appreciate the many individuals who have contributed to this book. Ken Levy, Sandy Testa, Mike Wolff, and Cliff Evans discussed their clinical work with me and contributed case studies seen throughout this book. I also appreciate the students in my senior seminar on abnormal psychology from a neuroscience perspective who over the years gave me insight into how to present the information seen throughout this book as well as finding new information and perspectives. Faculty from across the country were extremely helpful in their reviews of this book and suggestions. They include the following individuals:
Chinenye S. S. Asobiereonwu, Northcentral University
Andrea Bonior, Georgetown University
Cameo F. Borntrager, University
